Display options
Share it on

Indian J Plast Surg. 2014 Sep-Dec;47(3):427-31. doi: 10.4103/0970-0358.146638.

Long term assessment of intralipotherapy in Madelung's disease.

Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India

Silvia Scevola, Giovanni Nicoletti, Antonino Neri, Angela Faga

Affiliations

  1. Advanced Technologies for Regenerative Medicine and Inductive Surgery Research Centre, University of Pavia, Viale Brambilla 74, Italy.
  2. Advanced Technologies for Regenerative Medicine and Inductive Surgery Research Centre, University of Pavia, Viale Brambilla 74, Italy ; Department of Clinical Surgical Diagnostic and Pediatric Sciences, Plastic and Reconstructive Surgery, University of Pavia, Via Aselli 45, Italy ; Plastic and Reconstructive Surgery Unit, Salvatore Maugeri Research and Care Institute, Via Salvatore Maugeri 10, Italy.
  3. Radiology Unit, Salvatore Maugeri Research and Care Institute, Via Salvatore Maugeri 10, 27100 Pavia, Italy.

PMID: 25593434 PMCID: PMC4292126 DOI: 10.4103/0970-0358.146638

Abstract

Madelung's disease is characterised by multiple symmetric abnormal fat masses in the head, neck and upper limbs. Surgical excision or liposuction is the only realistic available option, although palliative in nature. The serial intralipotherapy with phosphatidylcholine/deoxycholate has been proposed as a non-invasive treatment of Madelung's disease. The authors used serial intralipotherapy with phosphatidylcholine/deoxycholate in two patients affected by Madelung's disease. Three injections per lesion per patient were performed with 1 month's interval. Pre- and 6 months' post-treatment dimensions were assessed with ultrasound scan and patients were observed along a 5 years' clinical follow-up. A 42.5% average size reduction was reported in all treated lesions. About 33% recurrence rate was observed in the 5 years' follow-up. We confirm the efficacy of intralipotherapy in the non-invasive palliative treatment of Madelung's disease, as a valid option to reduce the volume and limit the growth of the pathological adipose masses.

Keywords: Deoxycholate; Madelung's disease; intralipotherapy; phosphatidylcholine; ultrasounds

References

  1. HNO. 1986 Nov;34(11):474-6 - PubMed
  2. Mutat Res. 2012 May 1;733(1-2):34-8 - PubMed
  3. Cancer Chemother Pharmacol. 2006 Feb;57(3):295-300 - PubMed
  4. J Am Acad Dermatol. 1988 Feb;18(2 Pt 1):359-62 - PubMed
  5. Prog Clin Biol Res. 1988;259:105-29 - PubMed
  6. Dermatol Surg. 2008 Jan;34(1):60-6; discussion 66 - PubMed
  7. Dermatol Surg. 2008 Apr;34(4):529-42; discussion 542-3 - PubMed
  8. Aesthetic Plast Surg. 2010 Apr;34(2):153-6 - PubMed
  9. J Hepatol. 2007 Jul;47(1):83-92 - PubMed
  10. Hepatogastroenterology. 2009 Mar-Apr;56(90):481-4 - PubMed
  11. Z Gastroenterol. 2011 Mar;49(3):340-3 - PubMed
  12. Medicine (Baltimore). 1984 Jan;63(1):56-64 - PubMed
  13. J Cutan Med Surg. 2006 Jul-Aug;10 (4):155-9 - PubMed
  14. Dermatol Surg. 2006 Apr;32(4):465-80 - PubMed

Publication Types